Abstract

Objective: The objective of the study was to develop a simple and rapid chromatographic method for quantification of escitalopram oxalate and flupentixol dihydrochloride in combined dosage form and plasma.
 Methods: The separation was achieved with a sun fire C8 [150×4.6 mm] 3.5 µm column with an isocratic mobile phase containing a mixture of potassium dihydrogen orthophosphate buffer: methanol: acetonitrile [30:60:10 v/v/v] pH adjusted to 11. The flow rate of the mobile phase was 1.5 ml/min with a Photodiode array [PDA] detection at 230 nm.
 Results: The HPLC method was developed and validated with respective linearity, accuracy, and precision, detection of limit, robustness, and specificity. The precision of the results stated as the relative standard deviation was below 2 %. The calibration curve was linear over a concentration range from 10-50 µg/ml for escitalopram oxalate and 1-5 µg/ml for flupentixol dihydrochloride with a correlation co-efficient 0.994 and 0.977 respectively. The accuracy of the method was demonstrated at levels in the range of 100 % and 120 % of the specification limit. The recovery of escitalopram oxalate and flupentixol dihydrochloride was found to be in the range of 90 % to 88 %, respectively. The lowest detection limits were found to be 2 µg/ml for escitalopram oxalate and 0.1 µg/ml for flupentixol dihydrochloride. The lowest quantification limits were found to be 5 µg/ml of escitalopram oxalate and 0.5 µg/ml of flupentixol dihydrochloride.
 Conclusion: The developed method was validated for linearity, accuracy, precision, the limit of detection and quantification, specificity. The method was applied successfully for the determination of escitalopram oxalate and flupentixol dihydrochloride in the combined dosage form and plasma.

Highlights

  • Depression is a mood disorder that causes a persistent feeling of sadness and loss of interest, called a major depressive disorder or clinical depression, it affects feel, think, and behave and can lead to a variety of emotional and physical problems

  • Liquid chromatographic methods and UV first derivative methods have been developed for ESC and FLU in pharmaceutical dosage form [11,12,13,14]

  • To the best of our knowledge, no information related to the high-performance liquid chromatography determination of ESC and FLU in pharmaceutical dosage form and plasma has ever been mentioned in the literature

Read more

Summary

Introduction

Depression is a mood disorder that causes a persistent feeling of sadness and loss of interest, called a major depressive disorder or clinical depression, it affects feel, think, and behave and can lead to a variety of emotional and physical problems. Escitalopram oxalate [ESC] is an orally administered selective serotonin reuptake inhibitor. It is the pure S enantiomers of racemic bicyclic phthalate derivative of citalopram. ESC belongs to a class of drugs known as Selective Serotonin Reuptake Inhibitors [SSRI]. It may improve your energy level and feelings of well-being and decrease nervousness. Flupentixol dihydrochloride [FLU] is an antipsychotic narcoleptic drug It is a thioxanthene and closely related to the phenothiazines. Liquid chromatographic methods and UV first derivative methods have been developed for ESC and FLU in pharmaceutical dosage form [11,12,13,14]. The developed method was validated according to the ICH guidelines [15]

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.